165 related articles for article (PubMed ID: 8094897)
1. Dopaminergic treatment of restless legs and rebound phenomenon.
Guilleminault C; Cetel M; Philip P
Neurology; 1993 Feb; 43(2):445. PubMed ID: 8094897
[No Abstract] [Full Text] [Related]
2. Restless legs syndrome.
Feigen A
JAMA; 1995 Oct; 274(15):1191-2. PubMed ID: 7563499
[No Abstract] [Full Text] [Related]
3. My doctor prescribed Sinemet for my restless legs and it was a catastrophe. Why did you recommend it in a recent article?
Johns Hopkins Med Lett Health After 50; 1998 Feb; 10(12):8. PubMed ID: 9916583
[No Abstract] [Full Text] [Related]
4. Augmentation of the restless legs syndrome with carbidopa/levodopa.
Allen RP; Earley CJ
Sleep; 1996 Apr; 19(3):205-13. PubMed ID: 8723377
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.
Kaplan PW; Allen RP; Buchholz DW; Walters JK
Sleep; 1993 Dec; 16(8):717-23. PubMed ID: 8165385
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic augmentation of restless legs syndrome.
García-Borreguero D; Williams AM
Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
[TBL] [Abstract][Full Text] [Related]
7. L-dopa in uremic patients with the restless legs syndrome.
Sandyk R; Bernick C; Lee SM; Stern LZ; Iacono RP; Bamford CR
Int J Neurosci; 1987 Aug; 35(3-4):233-5. PubMed ID: 3654080
[TBL] [Abstract][Full Text] [Related]
8. Transient restless legs-like syndrome as a complication of opiate withrawal.
Scherbaum N; Stüper B; Bonnet U; Gastpar M
Pharmacopsychiatry; 2003; 36(2):70-2. PubMed ID: 12734764
[TBL] [Abstract][Full Text] [Related]
9. [Restless legs, restless nights: therapeutic options in RLS].
Kassubek J; Unrath A
MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
[No Abstract] [Full Text] [Related]
10. Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medications.
Raymond CB; Breland L; Wazny LD; Sood AR; Orsulak CD
CANNT J; 2010; 20(2):29-33; quiz 34-5. PubMed ID: 20642163
[No Abstract] [Full Text] [Related]
11. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.
Earley CJ; Allen RP
Sleep; 1996 Dec; 19(10):801-10. PubMed ID: 9085489
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
Perry D; Birthi P; Salles S; McDowell S
PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365
[No Abstract] [Full Text] [Related]
13. Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa.
Braun M; Cawello W; Andreas JO; Boekens H; Horstmann R
J Clin Pharmacol; 2009 Sep; 49(9):1047-55. PubMed ID: 19628729
[TBL] [Abstract][Full Text] [Related]
14. Entacapone prolongs the reduction of PLM by levodopa/carbidopa in restless legs syndrome.
Polo O; Ylä-Sahra R; Hirvonen K; Karvinen J; Vahteristo M; Ellmén J
Clin Neuropharmacol; 2007; 30(6):335-44. PubMed ID: 18090458
[TBL] [Abstract][Full Text] [Related]
15. The impact of restless legs syndrome: a familial case study.
Snider S
J Neurosci Nurs; 2013 Dec; 45(6):371-4. PubMed ID: 24217148
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up.
von Scheele C; Kempi V
Arch Neurol; 1990 Nov; 47(11):1223-4. PubMed ID: 1978661
[TBL] [Abstract][Full Text] [Related]
17. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
Paulus W; Trenkwalder C
Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of sensory limb discomfort of restless legs syndrome by pallidotomy.
Rye DB; DeLong MR
Ann Neurol; 1999 Nov; 46(5):800-1. PubMed ID: 10554004
[No Abstract] [Full Text] [Related]
19. Dopamine dysregulation syndrome in a patient with restless legs syndrome.
Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I
Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183
[TBL] [Abstract][Full Text] [Related]
20. Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel function.
Iyer SS; Morgan JC; Sethi KD
Neurology; 2005 Nov; 65(9):1507. PubMed ID: 16275853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
